Yu-Lin Su - Search Results

Year	Number of Results
2003	1
2015	2
2016	5
2018	6
2019	3
2020	5
2021	7
2022	2
2023	1
2024	0

1

Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s.

Li YY, Wang XJ, Su YL, Wang Q, Huang SW, Pan ZF, Chen YP, Liang JJ, Zhang ML, Xie XQ, Wu ZY, Chen JY, Zhou L, Luo X. Li YY, et al. Among authors: su yl. Acta Pharmacol Sin. 2022 Jun;43(6):1495-1507. doi: 10.1038/s41401-021-00781-7. Epub 2021 Oct 20. Acta Pharmacol Sin. 2022. PMID: 34671110 Free PMC article.

2

Functional Nanoparticles for Tumor Penetration of Therapeutics.

Su YL, Hu SH. Su YL, et al. Pharmaceutics. 2018 Oct 18;10(4):193. doi: 10.3390/pharmaceutics10040193. Pharmaceutics. 2018. PMID: 30340364 Free PMC article. Review.

3

STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity.

Su YL, Banerjee S, White SV, Kortylewski M. Su YL, et al. Int J Mol Sci. 2018 Jun 19;19(6):1803. doi: 10.3390/ijms19061803. Int J Mol Sci. 2018. PMID: 29921770 Free PMC article. Review.

4

Beclin-1 as a neutrophil-specific immune checkpoint.

Su YL, Kortylewski M. Su YL, et al. J Clin Invest. 2019 Dec 2;129(12):5079-5081. doi: 10.1172/JCI132534. J Clin Invest. 2019. PMID: 31657787 Free PMC article.

5

Functionalized graphene nanocomposites for enhancing photothermal therapy in tumor treatment.

Chen YW, Su YL, Hu SH, Chen SY. Chen YW, et al. Among authors: su yl. Adv Drug Deliv Rev. 2016 Oct 1;105(Pt B):190-204. doi: 10.1016/j.addr.2016.05.022. Epub 2016 Jun 2. Adv Drug Deliv Rev. 2016. PMID: 27262922 Review.

6

Rabies Virus Glycoprotein-Mediated Transportation and T Cell Infiltration to Brain Tumor by Magnetoelectric Gold Yarnballs.

Cheng W, Su YL, Hsu HH, Lin YH, Chu LA, Huang WC, Lu YJ, Chiang CS, Hu SH. Cheng W, et al. Among authors: su yl. ACS Nano. 2022 Mar 22;16(3):4014-4027. doi: 10.1021/acsnano.1c09601. Epub 2022 Feb 28. ACS Nano. 2022. PMID: 35225594

7

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors.

Zhao X, Zhang Z, Moreira D, Su YL, Won H, Adamus T, Dong Z, Liang Y, Yin HH, Swiderski P, Pillai RK, Kwak L, Forman S, Kortylewski M. Zhao X, et al. Among authors: su yl. Mol Ther. 2018 Mar 7;26(3):695-707. doi: 10.1016/j.ymthe.2018.01.007. Epub 2018 Jan 17. Mol Ther. 2018. PMID: 29433938 Free PMC article.

8

Jejunal Cavernous Hemangioma Mimicking Malignancy With Increased Activity on 18 F-FDG PET/CT.

Huang WS, He YL, Liang J, Su YL, Xu JH. Huang WS, et al. Among authors: su yl. Clin Nucl Med. 2023 May 1;48(5):409-410. doi: 10.1097/RLU.0000000000004620. Epub 2023 Mar 22. Clin Nucl Med. 2023. PMID: 36927765

9

Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia.

Nguyen LXT, Zhang B, Hoang DH, Zhao D, Wang H, Wu H, Su YL, Dong H, Rodriguez-Rodriguez S, Armstrong B, Ghoda LY, Perrotti D, Pichiorri F, Chen J, Li L, Kortylewski M, Rockne RC, Kuo YH, Khaled S, Carlesso N, Marcucci G. Nguyen LXT, et al. Among authors: su yl. Leukemia. 2021 Aug;35(8):2285-2298. doi: 10.1038/s41375-021-01166-9. Epub 2021 Feb 15. Leukemia. 2021. PMID: 33589748 Free PMC article.

10

Myeloid cell-targeted miR-146a mimic inhibits NF-κB-driven inflammation and leukemia progression in vivo.

Su YL, Wang X, Mann M, Adamus TP, Wang D, Moreira DF, Zhang Z, Ouyang C, He X, Zhang B, Swiderski PM, Forman SJ, Baltimore D, Li L, Marcucci G, Boldin MP, Kortylewski M. Su YL, et al. Blood. 2020 Jan 16;135(3):167-180. doi: 10.1182/blood.2019002045. Blood. 2020. PMID: 31805184 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

28 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year